Alyeska Investment Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.8M | Sell |
200,846
-1,107,240
| -85% | -$26.5M | 0.02% | 427 |
|
|
2025
Q1 | $32.5M | Buy |
+1,308,086
| New | +$32.5M | 0.13% | 191 |
|
|
2018
Q2 | – | Sell |
-648,920
| Closed | -$20.2M | – | 466 |
|
|
2018
Q1 | $20.2M | Sell |
648,920
-371,416
| -36% | -$11.6M | 0.17% | 145 |
|
|
2017
Q4 | $46.6M | Buy |
1,020,336
+381,393
| +60% | +$17.4M | 0.37% | 88 |
|
|
2017
Q3 | $24M | Sell |
638,943
-322,680
| -34% | -$12.1M | 0.18% | 157 |
|
|
2017
Q2 | $45.9M | Sell |
961,623
-451,570
| -32% | -$21.5M | 0.38% | 93 |
|
|
2017
Q1 | $64.4M | Buy |
1,413,193
+870,083
| +160% | +$39.7M | 0.52% | 55 |
|
|
2016
Q4 | $17.5M | Buy |
543,110
+501,374
| +1,201% | +$16.2M | 0.15% | 219 |
|
|
2016
Q3 | $1.43M | Buy |
+41,736
| New | +$1.43M | 0.01% | 390 |
|